Strategies and Impact of the National Anti Malaria Programme

Malaria has been one of India’s most persistent public health challenges. At the time of independence in 1947, the disease affected an estimated 75 million people annually, causing approximately 800,000 deaths. Over the decades, India launched several programs to combat this deadly disease, culminating in what we now know as the National Anti Malaria Programme (NAMP). This initiative marked a significant shift in how the country approached malaria control, moving from eradication dreams to practical, sustainable strategies for managing the disease.

Historical evolution of malaria control in India 🔗

India’s formal battle against malaria began with the National Malaria Control Programme (NMCP) launched in 1953. This programme focused primarily on indoor residual spraying (IRS) with DDT, monitoring and surveillance of cases, and treatment of patients. The results were remarkable. Within just a few years, malaria-related morbidity and mortality dropped significantly across the country.

Encouraged by this early success, the government converted the control programme into the National Malaria Eradication Programme (NMEP) in 1958. The ambitious goal was to completely eliminate malaria from India. By 1965, reported malaria cases had plummeted to just 99,667, and malaria deaths were nearly eliminated. This represented one of the most dramatic public health achievements in India’s post-independence history.

The resurgence of malaria 🔗

Unfortunately, success bred complacency. After 1967, administrative and technical challenges began undermining the programme’s effectiveness. The situation deteriorated rapidly, and by 1976, India witnessed a massive resurgence with 6.46 million cases reported. This surge was attributed to poor health infrastructure, suboptimal monitoring, and logistics failures in many parts of the country.

Additionally, the malaria mosquito began developing resistance to insecticides, and the parasite showed growing resistance to antimalarial drugs like chloroquine. The first case of chloroquine-resistant malaria was reported from Assam in 1973, signalling a new challenge for health authorities.

Birth of the National Anti Malaria Programme 🔗

In response to the changing malaria landscape, the government introduced the Modified Plan of Operation in 1977. This plan emphasized a three-pronged strategy combining early diagnosis, prompt treatment, and selective vector control. The programme also established fever treatment depots and drug distribution centres at the village level to ensure antimalarial medicines reached remote and inaccessible areas.

The programme underwent another significant transformation in 1998 when the NMEP was renamed the National Anti-Malaria Programme (NAMP). This change acknowledged the shift in goals from eradication to sustainable control. The emphasis moved toward reducing disease burden in a cost-effective and integrated manner rather than pursuing the increasingly unrealistic goal of complete elimination.

Key strategies of NAMP 🔗

The National Anti Malaria Programme implemented several interconnected strategies to combat malaria effectively. These approaches formed the backbone of India’s malaria control efforts during this period.

Early case detection and prompt treatment 🔗

One of NAMP’s core strategies involved identifying malaria cases early and providing immediate treatment. The programme established both active and passive surveillance systems. Active case detection involved health workers visiting households to identify fever cases, while passive surveillance relied on patients presenting themselves at health facilities.

The programme maintained a network of drug distribution centres and fever treatment depots across rural India. According to programme data, approximately 3.57 lakh such centres were functioning across the country, ensuring antimalarial drugs remained accessible even in remote villages.

Indoor residual spraying 🔗

Indoor residual spraying remained a cornerstone of vector control under NAMP. The programme primarily used DDT for spraying on walls and other surfaces inside dwellings where female Anopheles mosquitoes rest before or after feeding. Research from Orissa demonstrated that DDT spraying could reduce indoor resting density of malaria vectors by 93-95%, significantly decreasing transmission.

However, the programme adopted a more selective approach to spraying. Rather than blanket coverage, IRS was targeted at high-risk areas based on epidemiological data. This selective strategy helped optimize resource utilization while maintaining effectiveness in areas that needed it most.

Integrated vector management 🔗

Beyond chemical spraying, NAMP promoted integrated vector management incorporating biological and environmental approaches. The programme encouraged the use of larvivorous fish in local water bodies to control mosquito breeding. Bio-larvicides were also introduced as environmentally friendlier alternatives to chemical pesticides.

The distribution of insecticide-treated bed nets became another important intervention. These nets provided personal protection, particularly for vulnerable populations like pregnant women and young children who face the highest risk of severe malaria.

Enhanced Malaria Control Project 🔗

To intensify efforts in high-burden areas, the Enhanced Malaria Control Project (EMCP) was launched in 1997 with World Bank support. This project directly benefited tribal populations across eight states, covering 100 districts and 19 urban areas. The selection criteria focused on areas with an Annual Parasite Incidence greater than 2 for at least three consecutive years.

The EMCP marked a shift from command-and-control approaches to community involvement and ownership. The project supported the government’s transition from attempting to control mosquitoes to emphasizing prevention, early detection, and prompt treatment of human cases.

Transition to NVBDCP 🔗

In 2003, NAMP acquired additional responsibilities and evolved into the National Vector Borne Disease Control Programme (NVBDCP). This integration brought together the control of multiple vector-borne diseases including malaria, dengue, lymphatic filariasis, kala-azar, Japanese encephalitis, and later chikungunya under a single umbrella programme.

The rationale behind this integration was that these diseases share common control strategies. Chemical controls, environmental management, biological control methods, and personal protection strategies could be implemented more efficiently through a unified programme structure rather than separate vertical initiatives.

Introduction of new tools and technologies 🔗

Following the transition to NVBDCP, several important innovations were introduced to strengthen malaria control. In 2005, monovalent Rapid Diagnostic Tests (RDTs) for detecting Plasmodium falciparum were introduced, enabling diagnosis at the community level without requiring microscopy facilities.

The following year, Artemisinin-based Combination Therapy (ACT) replaced chloroquine as the first-line treatment for falciparum malaria in resistant areas. This was a crucial policy change, as chloroquine resistance had spread extensively across the country. Long-lasting insecticidal nets (LLINs) were introduced in 2009, providing longer protection compared to conventional insecticide-treated nets.

Ending presumptive treatment 🔗

A major policy shift occurred in 2007 when the government discontinued presumptive treatment for malaria. Previously, all fever patients in endemic areas received chloroquine without laboratory confirmation. This practice had contributed to drug resistance development. The new policy mandated parasitological confirmation through microscopy or rapid diagnostic kits before prescribing antimalarial treatment.

Challenges that persisted 🔗

Despite significant progress, NAMP and its successor programmes faced several persistent challenges. The heterogeneous malaria endemicity across India meant that one-size-fits-all approaches were ineffective. Tribal and forested areas, home to approximately 6.6% of India’s population, contributed around 32% of malaria cases and 42% of deaths.

Insecticide resistance in malaria vectors posed another serious obstacle. Many areas reported vectors resistant to DDT, malathion, and even synthetic pyrethroids. This triple resistance complicated vector control operations and necessitated the development of new insecticide rotation strategies.

Healthcare access in remote areas 🔗

Reaching populations in inaccessible and remote areas remained a significant challenge. During monsoon and post-monsoon transmission seasons, many endemic areas became cut off from regular transportation and communication networks, making it extremely difficult to deliver health services when they were most needed.

The private healthcare sector, which caters to a large proportion of fever patients, was not adequately integrated into the national programme. This meant that treatment practices in the private sector often did not align with national guidelines, and case data from private providers were rarely captured in surveillance systems.

Impact and achievements 🔗

The various iterations of India’s malaria control programme achieved considerable success over time. According to the World Malaria Report 2024, India reduced malaria cases by approximately 80% between 2015 and 2023. Cases declined from over 1.1 million in 2015 to approximately 227,564 in 2023, while deaths fell from 384 to just 83 during the same period.

India has now committed to achieving malaria elimination by 2030 under the National Framework for Malaria Elimination launched in 2016. Several states and union territories have already achieved or are approaching zero indigenous malaria cases. As of 2023, Ladakh, Lakshadweep, and Puducherry reported zero indigenous cases, demonstrating that elimination is achievable with sustained effort.

Lessons for the future 🔗

The journey from NMCP through NAMP to NVBDCP offers valuable lessons for disease control programmes. Flexibility and adaptation proved essential as the epidemiological situation and available tools evolved. The shift from eradication to control, while initially seen as a retreat, ultimately enabled more sustainable and effective interventions.

Community engagement emerged as a critical success factor. The deployment of community health workers trained in diagnosis and treatment brought services closer to affected populations. Integration with broader health system strengthening initiatives like the National Rural Health Mission amplified the impact of malaria-specific interventions.

What do you think? How can India’s experience with malaria control inform approaches to other infectious diseases? What role should community health workers play in disease surveillance and treatment programmes?

References

1. https://dghs.gov.in/content/1364_3_NationalVectorBorneDiseaseControlProgramme.aspx
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC4001331/
3. https://pubmed.ncbi.nlm.nih.gov/15679559/
4. https://www.worldbank.org/en/news/feature/2010/04/23/malaria-indias-battle-against-a-complex-disease
5. https://www.nhp.gov.in/national-vector-borne-disease-control-programme_pg
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC9237895/
7. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2087878